Assessment of Patient Satisfaction Program "Gestational Diabetes" (SATISFYDG)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02945540|
Recruitment Status : Unknown
Verified September 2016 by University Hospital, Caen.
Recruitment status was: Recruiting
First Posted : October 26, 2016
Last Update Posted : October 26, 2016
This study seeks to evaluate patient satisfaction within the patient therapeutic education program "gestational diabetes" (multidisciplinary and multi-professional program) to see if they deem effective to limit the impact of gestational diabetes on pregnancy . Patients are questioned on the skills acquired in everyday life, the effective support in personal development, development of self-determination capabilities and communication with health professionals.
This study must include all patients participating in the therapeutic education program for a year and meeting the inclusion criteria.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||350 participants|
|Official Title:||Assessment of Patient Satisfaction Supported in the Patient Education Program "Gestational Diabetes" at the University Hospital of Caen|
|Study Start Date :||April 2016|
|Estimated Primary Completion Date :||April 2017|
|Estimated Study Completion Date :||April 2017|
- Measuring patient satisfaction by a questionnaire on therapeutic education [ Time Frame: 36th week of gestation ]Evaluation of satisfaction the entry into the program, after the diagnosis, until the 36th week of gestation.
- Measuring patient satisfaction at childbirth by a questionnaire on satisfaction of hospital care [ Time Frame: baseline ]Assessment of satisfaction between the 36th week of gestation and childbirth.
- Blood glucose self-monitoring [ Time Frame: until birth (up to a maximum of 16 weeks) ]control of diabetes by expected blood glucose targets
- weight gain [ Time Frame: during pregnancy until birth (up to a maximum of 16 weeks) ]
- type of birth [ Time Frame: baseline ]Mode of parturition : Cesarean section or vaginal birth
- Measure of abdominal diameter [ Time Frame: before childbirth ]Fetal Macrosomia suspected during fetal ultrasonography
- Measure of fetal weight [ Time Frame: before childbirth ]Fetal Macrosomia suspected during fetal ultrasonography
- Birth weight [ Time Frame: at childbirth ]
- Apgar score [ Time Frame: 1 minute and 5 minutes after birthchild ]
- Neonatal blood glucose measurement [ Time Frame: during the first 48 hours after birth ]Number of neonatal hypoglycemia
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02945540
|Contact: Lidwine TRONCY, MSc||+33 2 31 06 30 firstname.lastname@example.org|
|Caen University Hospital||Recruiting|
|Caen, France, 14033|
|Contact: Lidwine TRONCY, MSc +33 2 31 06 30 23 email@example.com|